GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Brighten Optix Corp (ROCO:6747) » Definitions » Debt-to-EBITDA

Brighten Optix (ROCO:6747) Debt-to-EBITDA : 0.30 (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Brighten Optix Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Brighten Optix's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was NT$9.2 Mil. Brighten Optix's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was NT$27.1 Mil. Brighten Optix's annualized EBITDA for the quarter that ended in Dec. 2023 was NT$122.6 Mil. Brighten Optix's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was 0.30.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Brighten Optix's Debt-to-EBITDA or its related term are showing as below:

ROCO:6747' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.06   Med: 0.21   Max: 2.01
Current: 0.12

During the past 9 years, the highest Debt-to-EBITDA Ratio of Brighten Optix was 2.01. The lowest was 0.06. And the median was 0.21.

ROCO:6747's Debt-to-EBITDA is ranked better than
85.88% of 432 companies
in the Medical Devices & Instruments industry
Industry Median: 1.21 vs ROCO:6747: 0.12

Brighten Optix Debt-to-EBITDA Historical Data

The historical data trend for Brighten Optix's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Brighten Optix Debt-to-EBITDA Chart

Brighten Optix Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only 0.24 0.18 0.07 0.06 0.12

Brighten Optix Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.21 0.08 0.09 0.08 0.30

Competitive Comparison of Brighten Optix's Debt-to-EBITDA

For the Medical Devices subindustry, Brighten Optix's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Brighten Optix's Debt-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Brighten Optix's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Brighten Optix's Debt-to-EBITDA falls into.



Brighten Optix Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Brighten Optix's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(9.153 + 27.111) / 291.819
=0.12

Brighten Optix's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(9.153 + 27.111) / 122.556
=0.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.


Brighten Optix  (ROCO:6747) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Brighten Optix Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Brighten Optix's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Brighten Optix (ROCO:6747) Business Description

Traded in Other Exchanges
N/A
Address
No. 150, Chengde Road, 6th Floor-1, Section 4, Shilin District, Taipei, TWN, 111
Brighten Optix Corp is a Taiwan-based company engaged in the manufacturing of contact lenses. The product offerings of the company include Corneal plastic film, Hard contact lenses, Customized soft contact lenses, Hard potion, and Other ancillary products.

Brighten Optix (ROCO:6747) Headlines

No Headlines